Concepedia

Anandharajan Rathinasabapathy

AR

13

Publications

984

Citations

12

H-Index

2013

Active since

Affiliations

Vanderbilt University Medical Center(Current)

University of Florida

Louisiana State University

Maastricht University

Brown University

Anandharajan Rathinasabapathy is an author at Vanderbilt University Medical Center specializing in medicine, vascular biology, and physiology.

ORCID

Top concepts

Publications per year

2013–2022

13

Publications

13

A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension

Anna R. Hemnes, Anandharajan Rathinasabapathy, Eric A. Austin et al. · European Respiratory Journal · 2018 · 224 citations · Full text

Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models

Vinayak Shenoy, Altin Gjymishka, Yagna Jarajapu et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 173 citations · Full text

Oral Delivery of Angiotensin-Converting Enzyme 2 and Angiotensin-(1-7) Bioencapsulated in Plant Cells Attenuates Pulmonary Hypertension

Vinayak Shenoy, Kwang‐Chul Kwon, Anandharajan Rathinasabapathy et al. · Hypertension · 2014 · 141 citations · Full text

, , +16

Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension

Toshio Suzuki, Erica J. Carrier, Megha Talati et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2017 · 103 citations · Full text

Selective activation of angiotensin<scp>AT</scp><sub>2</sub>receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis

Eugene N. Bruce, Vinayak Shenoy, Anandharajan Rathinasabapathy et al. · British Journal of Pharmacology · 2014 · 85 citations · Full text

Rows per page

1–5 of 13